Biomarkers


Biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials. Biomarkers that have been well characterized and repeatedly shown to correctly predict relevant clinical outcomes across a variety of treatments and populations; this use is entirely justified and appropriate. It is easy to imagine measurable Biological characteristics that do not correspond to patients' clinical state, or whose variations are undetectable and without effect on health. Surrogate endpoints are a small subset of well-characterized Biomarkers with well-evaluated clinical relevance. A Biomarker consistently and accurately predicts a clinical outcome, either a Benefit or harm.


    Related Conference of Biomarkers

    September 22-23, 2025

    29th Materials Science and Nano Tech Expo

    Amsterdam, Netherlands
    October 28-29, 2025

    3rd World Summit on Emerging Materials and Nanotechnology

    Vancouver, Canada
    October 28-29, 2025

    9th International Conference on Smart Materials

    Vancouver, Canada
    August 25-26, 2026

    19th Annual Conference on Stem Cell and Biomaterials

    Amsterdam, Netherlands

    Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in